Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Open access
Khanna, Dinesh, Gladue, Heather, Channick, Richard, Chung, Lorinda, Distler, Oliver, Furst, Daniel E., Hachulla, Eric, Humbert, Marc, Langleben, David, Mathai, Stephen C., Saggar, Rajeev, Visovatti, Scott, Altorok, Nezam, Townsend, Whitney, FitzGerald, John, McLaughlin, Vallerie V.·2013·Arthritis & Rheumatism

Abstract

Objective: Pulmonary arterial hypertension (PAH) affects up to 15% of patients with connective tissue diseases (CTDs). Previous recommendations developed as part of larger efforts in PAH did not include detailed recommendations for patients with CTD‐associated PAH. Therefore, we sought to develop recommendations for screening and early detection of CTD‐associated PAH. Methods: We performed a systematic review of the literature on the screening and diagnosis of PAH in CTD. Using the RAND/University of California, Los Angeles consensus methodology, we developed case scenarios followed by 2 stages of voting. First, international experts from a variety of specialties voted anonymously on the appropriateness of each case scenario. The experts then met face‐to‐face to discuss and resolve discrepant votes to arrive at consensus recommendations. Results: The key recommendation stated that all patients with systemic sclerosis (SSc) should be screened for PAH. In addition, patients with mixed connective tissue disease or other CTDs with scleroderma features (scleroderma spectrum disorders) should be screened for PAH. It was recommended that screening pulmonary function tests (PFTs) with single‐breath diffusing capacity for carbon monoxide, transthoracic echocardiogram, and measurement of N‐terminal pro–brain natriuretic peptide (NT‐proBNP) be performed in all patients with SSc and scleroderma spectrum disorders. In patients with SSc and scleroderma spectrum disorders, transthoracic echocardiogram and PFTs should be performed annually. The full screening panel (transthoracic echocardiogram, PFTs, and measurement of NT‐proBNP) should be performed as soon as any new signs or symptoms are present. Conclusion: We provide consensus‐based, evidence‐driven recommendations for screening and early detection of CTD‐associated PAH. It is our hope that these recommendations will lead to earlier detection of CTD‐associated PAH and ultimately improve patient outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38172

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 210

Metadata

Authors
Khanna, D., Gladue, H., Channick, R., Chung, L., Distler, O., Furst, D. E., Hachulla, E., Humbert, M., Langleben, D., Mathai, S. C., Saggar, R., Visovatti, S., Altorok, N., Townsend, W., FitzGerald, J., & McLaughlin, V. V.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2013-11-27
Volume
65
Issue
12
Pages
3194-3201
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1803413773
Cited by
210
References
4
FWCI
14.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension. https://app.cochat.ai/papers/10.1002/art.38172
The paper
Khanna, D., Gladue, H., Channick, R., Chung, L., Distler, O., Furst, D. E., Hachulla, E., Humbert, M., Langleben, D., Mathai, S. C., Saggar, R., Visovatti, S., Altorok, N., Townsend, W., FitzGerald, J., & McLaughlin, V. V. (2013). Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatism. https://doi.org/10.1002/art.38172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.